Why is SMS Pharmaceuticals Ltd falling/rising?

Recent Price Movement and Market Context

The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 12.09% in value. On the day in question, it touched an intraday low of ₹366.20, marking a 9.12% decline from previous levels. The trading session was characterised by a wide price range of ₹37.75, indicating significant intraday volatility. The weighted average price suggests that a larger volume of shares exchanged hands closer to the day’s low, signalling selling dominance during the session.

Despite this short-term weakness, SMS Pharmaceuticals has outperformed the broader market over longer periods. Year-to-date, the stock has gained 19.10%, contrasting sharply with the Sensex’s decline of 12.50%. Over the past year, the company’s shares have surged by an impressive 94.11%, vastly outpacing the Sensex’s modest 1.00% gain. Even over three and five years, SMS Pharmaceuticals has delivered stellar returns of 440.30% and 185.58% respectively, dwarfing the benchmark’s performance.

Technical Indicators and Investor Behaviour

From a technical standpoint, the stock’s current price remains above its 50-day, 100-day, and 200-day moving averages, reflecting a generally positive medium- to long-term trend. However, it is trading below its 5-day and 20-day moving averages, indicating short-term weakness and potential profit booking. The intraday volatility of 6.79% further emphasises the unsettled trading environment.

Investor participation appears to be waning, as evidenced by a 25.61% drop in delivery volume on 12 Mar compared to the five-day average. This decline in delivery volume suggests reduced conviction among buyers, possibly contributing to the recent price softness. Nevertheless, liquidity remains adequate, with the stock capable of handling trades worth approximately ₹0.49 crore based on recent average traded values.

Fundamental Strengths Supporting the Stock

Despite the recent price dip, SMS Pharmaceuticals boasts strong fundamentals that justify a hold stance for investors. The company reported a 9-month PAT of ₹69.27 crore, reflecting a robust growth rate of 41.89%. Net sales for the same period stood at ₹648.93 crore, up 21.40% year-on-year. Additionally, the company’s return on capital employed (ROCE) for the half-year period reached a healthy 12.36%, underscoring efficient utilisation of capital.

Promoter holdings remain substantial, providing stability and confidence in the company’s strategic direction. The consistent outperformance of the stock relative to the BSE500 index over the past three years further highlights its resilience and growth potential.

Balancing Short-Term Volatility with Long-Term Outlook

The recent decline in SMS Pharmaceuticals’ share price appears to be driven primarily by short-term profit-taking and increased volatility rather than any deterioration in the company’s core business metrics. The stock’s ability to maintain levels above key moving averages and its strong delivery volumes over time suggest that the current weakness may be temporary.

Investors should weigh the recent price correction against the company’s solid earnings growth, expanding sales base, and consistent outperformance relative to market benchmarks. While the stock has underperformed its sector by 6.52% on the day, its long-term trajectory remains positive, supported by strong fundamentals and promoter confidence.

In summary, SMS Pharmaceuticals Ltd’s recent price fall on 13-Mar reflects a phase of short-term volatility and reduced investor participation rather than fundamental concerns. The company’s impressive financial results and sustained market outperformance continue to underpin its investment appeal, suggesting that the current dip may offer a buying opportunity for long-term investors.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →